NU will be responsible for the development of PWS biomarkers of rectal colonocytes for colon cancer screening. NU will perform electron microscopy and PWS on de-identified specimens from BMC.
|Effective start/end date||9/30/17 → 8/31/20|
- Boston Medical Center (7R33CA225323-02//Backman AGMT 9/14/21)
- National Cancer Institute (7R33CA225323-02//Backman AGMT 9/14/21)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.